Nebivolol tablets bulk supplier for pharma manufacturers

Nebivolol Tablets 2.5 mg, 5 mg, and 10 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 2.5 mg, 5 mg, and 10 mg

Reference Brands: Bystolic(US & EU)

Nebivolol is a selective beta-1 blocker that reduces heart rate and blood pressure. It enhances nitric oxide release, causing vasodilation and improving blood flow. Benefits include effective hypertension and heart failure management, decreased cardiovascular risk, improved cardiac function, and long-term health benefits with fewer side effects.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: Nebivolol tablets, marketed as Bystolic, are approved in the US by the FDA and in the EU via EMA for hypertension and heart failure. Regulatory approval requires detailed dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews comprehensive clinical and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper regional adherence supports rapid approval, safe use, and global availability of nebivolol tablets, helping patients worldwide manage cardiovascular health effectively and sustainably.

Nebivolol Tablets — third party manufacturing & bulk supply

Nebivolol Tablets 2.5 mg, 5 mg, and 10 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Nebivolol Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Nebivolol Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Nebivolol Tablets →

Back to Listing

Frequently Asked Questions

Nebivolol tablets is listed as Tablets in 2.5 mg, 5 mg, and 10 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Nebivolol tablets is referenced against Bystolic(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.